Related Experiment Videos
[A guide for osteoporosis management].
Arturo Zárate1, Renata Saucedo, Lourdes Basurto
1Unidad de Investigación Médica de Enfermedades Endocrinas, Hospital de Especialidades, Centro Médico Nacional IMSS. zaratre@att.net.mx
Gaceta Medica De Mexico
|May 28, 2004
Summary
Osteoporosis treatment aims to prevent fractures using medications like bisphosphonates and parathyroid hormone. Treatment choice depends on individual factors, and adherence is hindered by cost and poor patient information.
Area of Science:
- Gerontology
- Orthopedics
- Endocrinology
Context:
- Osteoporosis is a significant risk factor for fractures, leading to morbidity and mortality.
- Bone mass index measurements for osteoporosis have limitations.
- Fractures, particularly vertebral and hip, are major complications of osteoporosis.
Purpose:
- To outline current therapeutic strategies for osteoporosis.
- To highlight factors influencing treatment selection.
- To identify barriers to treatment adherence.
Summary:
- Antiresorptive drugs (bisphosphonates, estrogens, raloxifene) and anabolic agents (synthetic parathyroid hormone) are effective in preventing osteoporotic fractures.
- Calcium and vitamin D supplementation alone are insufficient for treating osteoporosis.
- Treatment decisions are individualized based on age, fracture history, and bone mineral density (BMD) at the spine and hip.
Impact:
- Effective management of osteoporosis can reduce fracture-related morbidity and mortality.
- Optimizing treatment adherence is crucial for long-term patient outcomes.
- Further research may address cost and patient education barriers to improve osteoporosis care.